105 related articles for article (PubMed ID: 18360689)
1. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha.
Asakawa A; Toyoshima M; Harada KH; Fujimiya M; Inoue K; Koizumi A
Int J Mol Med; 2008 Apr; 21(4):439-45. PubMed ID: 18360689
[TBL] [Abstract][Full Text] [Related]
2. Perfluorooctane sulfonate influences feeding behavior and gut motility via the hypothalamus.
Asakawa A; Toyoshima M; Fujimiya M; Harada K; Ataka K; Inoue K; Koizumi A
Int J Mol Med; 2007 May; 19(5):733-9. PubMed ID: 17390077
[TBL] [Abstract][Full Text] [Related]
3. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
Wolf DC; Moore T; Abbott BD; Rosen MB; Das KP; Zehr RD; Lindstrom AB; Strynar MJ; Lau C
Toxicol Pathol; 2008 Jun; 36(4):632-9. PubMed ID: 18467680
[TBL] [Abstract][Full Text] [Related]
4. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
Rosen MB; Abbott BD; Wolf DC; Corton JC; Wood CR; Schmid JE; Das KP; Zehr RD; Blair ET; Lau C
Toxicol Pathol; 2008 Jun; 36(4):592-607. PubMed ID: 18467677
[TBL] [Abstract][Full Text] [Related]
5. Transactivation potencies of the Baikal seal (Pusa sibirica) peroxisome proliferator-activated receptor α by perfluoroalkyl carboxylates and sulfonates: estimation of PFOA induction equivalency factors.
Ishibashi H; Kim EY; Iwata H
Environ Sci Technol; 2011 Apr; 45(7):3123-30. PubMed ID: 21381677
[TBL] [Abstract][Full Text] [Related]
6. Expression of a novel cytochrome P450 4T gene in rare minnow (Gobiocypris rarus) following perfluorooctanoic acid exposure.
Liu Y; Wang J; Liu Y; Zhang H; Xu M; Dai J
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jul; 150(1):57-64. PubMed ID: 19258050
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.
Rosen MB; Thibodeaux JR; Wood CR; Zehr RD; Schmid JE; Lau C
Toxicology; 2007 Sep; 239(1-2):15-33. PubMed ID: 17681415
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
Griesbacher T; Pommer V; Schuligoi R; Tiran B; Peskar BA
Int Immunopharmacol; 2008 Feb; 8(2):325-9. PubMed ID: 18182248
[TBL] [Abstract][Full Text] [Related]
9. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Lo Verme J; Fu J; Astarita G; La Rana G; Russo R; Calignano A; Piomelli D
Mol Pharmacol; 2005 Jan; 67(1):15-9. PubMed ID: 15465922
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA).
Guruge KS; Yeung LW; Yamanaka N; Miyazaki S; Lam PK; Giesy JP; Jones PD; Yamashita N
Toxicol Sci; 2006 Jan; 89(1):93-107. PubMed ID: 16221955
[TBL] [Abstract][Full Text] [Related]
11. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricularly administered urocortin inhibits gastric emptying in mice.
Nagata T; Uemoto M; Yuzuriha H; Asakawa A; Inui A; Fujimiya M; Sakamaki R; Kasuga M; Shinfuku N
Int J Mol Med; 2005 Jun; 15(6):1041-3. PubMed ID: 15870911
[TBL] [Abstract][Full Text] [Related]
13. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus).
Wei Y; Liu Y; Wang J; Tao Y; Dai J
Toxicol Appl Pharmacol; 2008 Feb; 226(3):285-97. PubMed ID: 17976672
[TBL] [Abstract][Full Text] [Related]
14. Pipping success and liver mRNA expression in chicken embryos exposed in ovo to C8 and C11 perfluorinated carboxylic acids and C10 perfluorinated sulfonate.
O'Brien JM; Crump D; Mundy LJ; Chu S; McLaren KK; Vongphachan V; Letcher RJ; Kennedy SW
Toxicol Lett; 2009 Oct; 190(2):134-9. PubMed ID: 19595750
[TBL] [Abstract][Full Text] [Related]
15. Urea cycle gene expression is suppressed by PFOA treatment in rats.
Walters MW; Wallace KB
Toxicol Lett; 2010 Aug; 197(1):46-50. PubMed ID: 20452409
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
17. Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?
Jiang Q; Lust RM; DeWitt JC
J Toxicol Environ Health A; 2013; 76(11):635-50. PubMed ID: 23941634
[TBL] [Abstract][Full Text] [Related]
18. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice.
Son HY; Lee S; Tak EN; Cho HS; Shin HI; Kim SH; Yang JH
Environ Toxicol; 2009 Dec; 24(6):580-8. PubMed ID: 19051282
[TBL] [Abstract][Full Text] [Related]
19. Perfluorinated compounds: occurrence and risk profile.
Kovarova J; Svobodova Z
Neuro Endocrinol Lett; 2008 Oct; 29(5):599-608. PubMed ID: 18987583
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3.
Asakawa A; Fujimiya M; Niijima A; Fujino K; Kodama N; Sato Y; Kato I; Nanba H; Laviano A; Meguid MM; Inui A
Psychoneuroendocrinology; 2010 Sep; 35(8):1178-86. PubMed ID: 20188481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
